A&B Zdrowie, Barbara Halejak, Agnieszka Jankowska, sp.j.

TAX ID8393173663

KRS0000482319

Not confirmed

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

Zjednoczenia 35, 76-248 Dębnica Kaszubska

Show on map

Register Data

Full name

A&B ZDROWIE, BARBARA HALEJAK, SPÓŁKA JAWNA

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. POLNA 2, 76-270 USTKA

Show on map

NIP

8393173663

REGON

221980349

KRS

0000482319

Legal form

general partnership

ALEO.com Registration Date

2017-08-19

Register Address

UL. POLNA 2, 76-270 USTKA

Date of registration in KRS

2013-10-25

Date of commencement of economic activity

2013-10-25

Act signature

RDF/669090/24/814

Pkd codes

47.73.Z - Dispensing chemist in specialised stores

21.20.Z - Manufacture of medicines and other pharmaceutical products

47.29.Z - Other retail sale of food in specialised stores

47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores

47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores

82.99.Z - Other business support service activities not elsewhere classified

Payer VAT status

Active

Vat list bank account(s)

PL76 2490 0005 0000 4530 2192 3430

PL83 1950 0001 2006 0826 2871 0002

Company authorities

representation authorityREPRESENTING THE COMPANY PARTNERS

representation type

KAŻDY WSPÓLNIK MA PRAWO I OBOWIĄZEK REPREZENTOWAĆ SPÓŁKĘ SAMODZIELNIE W SPRAWACH Z ZAKRESU ZWYKŁEGO ZARZĄDU. W TYCH TEŻ SPRAWACH WSPÓLNIK MA PRAWO I OBOWIĄZEK PROWADZENIA SAMODZIELNIE SPRAW SPÓŁKI.

REPRESENTING THE COMPANY PARTNERS

Barbara Ewa Halejak

42 years old

Beata Halejak

39 years old

shareholders

Barbara Ewa Halejak

Beata Halejak

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale	1,1	0,9	0,4	-53,4
Gross profit (loss)	1,1	3,5	0,4	-87,4
EBITDA	1,2	3,6	0,4	-87,6
Short time liabilities	0,9	0,2	0,3	17,9
Other operating costs	0	1	0	-98,2
Equity capital	0,7	2,9	0,9	-69
Operating profit (EBIT)	1,1	3,5	0,4	-87,5
Assets	1,7	3,1	1,2	-62,8
Net profit (loss)	1,1	3,5	0,4	-87,4
Cash	0,2	2,5	0,1	-94,6
Liabilities and provisions for liabilities	1	0,2	0,3	17,9
Net income from sale	12,6	10,4	3,9	-62,9
Working assets	1,6	3,1	1,2	-62,8
Other income costs	0	3,7	0,1	-98,3
Depreciation	0	0	0	-100
	%	%	%	p.p.
Profitability of capital	165,8	121,2	49,2	-72
Equity capital to total assets	38,8	92,9	77,4	-15,5
Gross profit margin	8,7	33,7	11,4	-22,3
EBITDA Margin	9,3	34,2	11,5	-22,7
	Days	Days	Days	Days
Short term commitment turnover cycle	26	8	25	17

Current financial liquidity indicator	1.7633379697799683	14.028743743896484	4.427056312561035	-9,6
Net dept to EBITDA	0.138717919588089	-0.7029687166213989	-0.30548930168151855	0,4